Should You Repeat LDH and Inhibin B Labs After Ultrasound Shows Simple Cyst Instead of Complex Cyst?
No, you should not repeat the LDH and inhibin B labs now that the repeat ultrasound demonstrates a simple cyst, as these tumor markers have no clinical utility in the evaluation of simple ovarian cysts, which carry essentially zero malignancy risk regardless of size or menopausal status. 1
Rationale for Not Repeating Labs
Simple Cysts Are Not Associated With Malignancy
- Simple ovarian cysts, regardless of size and menopausal status, are not associated with an increased risk of cancer. 1
- Large studies have demonstrated that simple cysts have a malignancy risk of 0 to 0.5 cases per 10,000 women at 3-year follow-up. 2
- In premenopausal women specifically, no simple cysts were diagnosed as cancer in a study of 12,957 cysts over 11 years. 2
LDH and Inhibin B Are Not Relevant to Simple Cyst Evaluation
- LDH is a nonspecific marker of cellular injury found in most cells and has no established role in differentiating benign from malignant ovarian cysts. 3
- The literature on LDH in cystic lesions pertains to breast cyst fluid analysis, not ovarian pathology, and even there it reflects cyst evolution rather than malignancy risk. 4, 5
- Inhibin B is a tumor marker sometimes used in the evaluation of granulosa cell tumors and other sex cord-stromal tumors, but it has no role in the assessment of simple cysts.
The Change From Complex to Simple Cyst Is Diagnostically Significant
- The initial "complex" appearance was likely a hemorrhagic or functional cyst that has now resolved to a simple cyst, which is the expected natural history of functional ovarian cysts. 1, 2
- Hemorrhagic functional cysts decrease or resolve on sonographic follow-up in 8-12 weeks, which explains the evolution from complex to simple morphology. 1
Management Based on Current Simple Cyst Finding
If Premenopausal
- Simple cysts <5 cm require no follow-up imaging or laboratory testing. 2
- Simple cysts 5-10 cm may warrant a single follow-up ultrasound at 8-12 weeks to confirm stability, but no tumor markers are indicated. 2
If Postmenopausal
- Simple cysts >3 cm (or >5 cm if exceptionally well visualized) may require follow-up imaging, but again, tumor markers are not part of the surveillance strategy. 6
Critical Pitfalls to Avoid
- Do not order tumor markers for simple cysts. The O-RADS classification system, which is the current standard for ovarian cyst risk stratification, does not incorporate tumor markers in the evaluation of O-RADS 2 (simple cyst) lesions. 1, 6
- Ensure the cyst truly meets simple cyst criteria: anechoic, smooth thin wall (<3 mm), no internal elements, acoustic enhancement, and no solid components. 2, 6
- The slightly elevated LDH and inhibin B from your initial evaluation were likely false positives or unrelated to the ovarian finding, as these markers have no validated role in simple cyst assessment.
What the Initial Elevation Likely Represented
- The initial complex appearance may have been a hemorrhagic corpus luteum cyst with internal echoes, which can occasionally be associated with nonspecific laboratory abnormalities. 1
- Now that the cyst has evolved to simple morphology, this confirms its benign functional nature and negates any concern that prompted the initial tumor marker testing.